Author details

Full Name

Helena T Hogberg

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34882777	Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0).	Altex	2022
35398340	Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.	Neurobiol Dis	2022
36359807	The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.	Cells	2022
36337915	Editorial: Methods and protocols in neurotoxicology.		2022
35404466	The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessaryâ¿¦ and possible.	Altex	2022
35295222	The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing.		2022
35239145	A human-derived 3D brain organoid model to study JC virus infection.	Journal of NeuroVirology	2022
35032963	COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.	Altex	2022
34360696	Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity.	Int J Mol Sci	2021
34259569	Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.	Environ Health Perspect	2021
33438114	Advances in 3D neuronal microphysiological systems: towards a functional nervous system on a chip.	In Vitro Cell Dev Biol Anim	2021
33078273	Organophosphorus flame retardants are developmental neurotoxicants in a rat primary brainsphere in vitro model.	Arch Toxicol	2021
34502381	Human IPSC-Derived Model to Study Myelin Disruption.	International Journal of Molecular Sciences	2021
34612677	Beyond Cholinesterase Inhibition: Developmental Neurotoxicity of Organophosphate Ester Flame Retardants and Plasticizers.	Environmental Health Perspectives	2021
34698363	COVID-19 - prime time for microphysiological systems, as illustrated for the brain.	ALTEX	2021
35296123	A Brainer on Neurotoxicity.		2020
32113184	Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development	ALTEX	2020
32153365	Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model.	Front Cell Neurosci	2020
32591839	Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2	ALTEX	2020
31329255	Corrigendum to Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity.	Altex	2019
30633302	Toward Good In Vitro Reporting Standards.	ALTEX	2019
31159811	Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.	Part Fibre Toxicol	2019
29428530	Rotenone exerts developmental neurotoxicity in a human brain spheroid model.	Toxicol Appl Pharmacol	2018
29955902	Toxicity, recovery, and resilience in a 3D dopaminergic neuronal in vitro model exposed to rotenone.	Arch Toxicol	2018
30619100	Microglia Increase Inflammatory Responses in iPSC-Derived Human BrainSpheres.	Front Microbiol	2018
29447839	Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.	Toxicol Appl Pharmacol	2018
29485663	Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.	Altex	2018
28110483	Explosive Blast Loading on Human 3D Aggregate Minibrains.	Cellular and Molecular Neurobiology	2017
28777440	3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects.	Curr Protoc Toxicol	2017
27143523	Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening.	J Appl Toxicol	2017
27452664	Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.	ALTEX	2017
27883356	A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.	ALTEX	2017
27722368	Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis.	Lab Chip	2016
26647301	A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.	Arch Toxicol	2016
26536290	Quality assurance of metabolomics.	ALTEX	2015
25618548	International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.	Arch Toxicol	2015
24687333	Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.	ALTEX	2014
24443875	Mapping the human toxome by systems toxicology.	Basic Clin Pharmacol Toxicol	2014
24127042	Pathways of Toxicity.	ALTEX	2014
24912505	Biological and medical applications of a brain-on-a-chip.	Exp Biol Med (Maywood)	2014
25027500	State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.	ALTEX	2014
24564953	Toward a 3D model of human brain development for studying gene/environment interactions.	Stem Cell Res Ther	2013
23665807	Metabolomics in toxicology and preclinical research.	ALTEX	2013
23724060	Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain.	PLoS One	2013
23722930	Review: toxicometabolomics.	J Appl Toxicol	2013
22135676	Domoic Acid-Induced Neurotoxicity Is Mainly Mediated by the AMPA/KA Receptor: Comparison between Immature and Mature Primary Cultures of Neurons and Glial Cells from Rat Cerebellum.	Journal of Toxicology	2011
21056592	Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons.	NeuroToxicology	2011
21878665	Î²â¿-Adrenergic receptors increase UCP1 in human MADS brown adipocytes and rescue cold-acclimated Î²â¿¿-adrenergic receptor-knockout mice via nonshivering thermogenesis.	American Journal of Physiology - Endocrinology and Metabolism	2011
21993959	tâ´ workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials.	ALTEX	2011
19969020	In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.	Neurotoxicology	2010